Vegf And Receptors
Mostrando 13-24 de 107 artigos, teses e dissertações.
-
13. Papel dos receptores canabinóides em um modelo experimental de angiogênese inflamatória
Angiogenesis depends on a complex network of cells and mediators. The activation or blockade of cannabinoid receptors showed to be an interesting pharmacological strategy to attenuate the angiogenic and/or inflammatory response in many experimental models. Here we investigated how this strategy may interfere in inflammatory angiogenesis. Polyester-polyuretha
Publicado em: 2007
-
14. Effect of vascular endothelial growth factor receptors inhibition on tumor angiogenesis in head and neck squamous cell carcinoma / Efeito da inibição dos receptores de fator de crescimento endotelial vascular na angiogênese tumoral em carcinomas espinocelulares de cabeça e pescoço
O fator de crescimento endotelial vascular (VEGF) tem sido considerado o principal indutor da angiogênese tumoral por sua ligação a receptores específicos tirosina-quinase presentes nas células endoteliais (VEGFR). Uma importante via reguladora da angiogênese é caracterizada pela ligação do VEGF ao seu receptor VEGFR-2 ativando a via de sinalizaçã
Publicado em: 2007
-
15. Expression of mRNA of the VEGF, Flt-1 and KDR in placentome, interplacentomal areas and gestational corpus luteum in different phases of pregnancy in cloned and non-cloned bovines / Expressão do mRNA do VEGF, FIt-1 e KDR no placentoma, região interplacentomal e corpo lúteo em diferentes fases gestacionais em bovinos clonados e não clonados
The VEGF is a specific endothelial mitogenic factor that promotes feto-maternal cell differentiation in placenta through binding to its receptors (Flt-1 and KDR). Their expression is controlled by autocrine and paracrine mechanisms that are associated to placenta development. The bovine placenta was used in this study as a model due to easiness of evaluation
Publicado em: 2006
-
16. ROLE OF Bcl-2 AND Bcl-XL IN ANGIOGENESIS
(...)Angiogenesis is defined as the development of new capillaries from pre-existing blood vessels. The hypothesis that tumor growth is angiogenesis dependent was proposed by Judah Folkman in 1971, and it has been confirmed by many investigators thereafter. We have shown that vascular endothelial growth factor (VEGF) induces Bcl-2 expression in endothelial c
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 2006
-
17. Immunolocalization of VEGF, bFGF and their receptors in the bovine placenta and influence of these growth factors on progesterone production from placental cells in culture / Imunolocalização do VEGF, bFGF e seus receptores na placenta bovina e influência destes fatores sobre a produção de progesterona pelas células placentárias em cultura
Placental establishment and function are dependent on intense vascularization. Placental vasculogenesis and angiogenesis are modulated by several factors, including VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor). Although the role of VEGF and bFGF during vascularization is already well established, some studies have indic
Publicado em: 2005
-
18. VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors
Sphingosine 1-phosphate (S1P) is a platelet-derived sphingolipid that binds to S1P1 (EDG-1) receptors and activates the endothelial isoform of NO synthase (eNOS). S1P and the polypeptide growth factor vascular endothelial growth factor (VEGF) act independently to modulate angiogenesis and activate eNOS. In these studies, we explored the cross-talk between S1
National Academy of Sciences.
-
19. Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide
Modulating angiogenesis is an attractive goal because many pathological conditions depend on the growth of new vessels. Angiogenesis is mainly regulated by the VEGF, a mitogen specific for endothelial cells. In the last years, many efforts have been pursued to modulate the angiogenic response targeting VEGF and its receptors. Based on the x-ray structure of
National Academy of Sciences.
-
20. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
We have identified a member of the VEGF family by computer-based homology searching and have designated it VEGF-D. VEGF-D is most closely related to VEGF-C by virtue of the presence of N- and C-terminal extensions that are not found in other VEGF family members. In adult human tissues, VEGF-D mRNA is most abundant in heart, lung, skeletal muscle, colon, and
The National Academy of Sciences.
-
21. Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia
Vascular endothelial growth factor (VEGF) is a hypoxia-inducible angiogenic peptide with recently identified neurotrophic effects. Because some neurotrophic factors can protect neurons from hypoxic or ischemic injury, we investigated the possibility that VEGF has similar neuroprotective properties. In HN33, an immortalized hippocampal neuronal cell line, VEG
The National Academy of Sciences.
-
22. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.
Endothelial cells constitute an essential integrator of factors that effect blood vessel remodeling induced by chronic hypoxia. We hypothesized that vascular endothelial growth factor (VEGF) may participate in the lung response to acute and to chronic hypoxia. We found that ex vivo perfusion of isolated lungs under hypoxic conditions (when compared with norm
-
23. VEGF-Trap: A VEGF blocker with potent antitumor effects
Vascular endothelial growth factor (VEGF) plays a critical role during normal embryonic angiogenesis and also in the pathological angiogenesis that occurs in a number of diseases, including cancer. Initial attempts to block VEGF by using a humanized monoclonal antibody are beginning to show promise in human cancer patients, underscoring the importance of opt
National Academy of Sciences.
-
24. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets
The roles of proteinase-activated receptors (PARs) in platelet functions other than aggregation are not well understood. Among these is the release of factors that regulate the process of angiogenesis, such as endostatin and VEGF, which, respectively, inhibit and promote angiogenesis. PAR1 and PAR4 are expressed on the surface of human platelets and can be a
National Academy of Sciences.